ProKidney Corp. (PROK)
NASDAQ: PROK · IEX Real-Time Price · USD
2.710
+0.180 (7.11%)
At close: Apr 24, 2024, 4:00 PM
2.719
+0.009 (0.33%)
After-hours: Apr 24, 2024, 7:59 PM EDT
ProKidney Market Cap
ProKidney has a market cap or net worth of $623.08 million as of April 24, 2024. Its market cap has decreased by -79.60% in one year.
Market Cap
623.08M
Enterprise Value
264.54M
1-Year Change
-79.60%
Ranking
Category
Stock Price
$2.71
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $258.80M to $623.08M, an increase of 140.76%. That is a compound annual growth rate of 36.57%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 621.50M | 7.12% |
Apr 23, 2024 | 580.20M | -6.99% |
Apr 22, 2024 | 623.80M | 33.32% |
Apr 19, 2024 | 467.90M | -14.99% |
Apr 18, 2024 | 550.40M | -15.49% |
Apr 17, 2024 | 651.30M | 4.41% |
Apr 16, 2024 | 623.80M | 30.15% |
Apr 15, 2024 | 479.30M | 19.41% |
Apr 12, 2024 | 401.40M | 6.73% |
Apr 11, 2024 | 376.10M | 13.11% |
Apr 10, 2024 | 332.50M | -2.69% |
Apr 9, 2024 | 341.70M | 1.36% |
Apr 8, 2024 | 337.10M | -1.35% |
Apr 5, 2024 | 341.70M | 3.45% |
Apr 4, 2024 | 330.30M | -3.34% |
Apr 3, 2024 | 341.70M | 1.01% |
Apr 2, 2024 | 338.30M | -7.80% |
Apr 1, 2024 | 366.90M | -2.45% |
Mar 28, 2024 | 376.10M | 4.44% |
Mar 27, 2024 | 360.10M | -1.26% |
Mar 26, 2024 | 364.70M | 10.41% |
Mar 25, 2024 | 330.30M | 2.87% |
Mar 22, 2024 | 321.10M | -0.43% |
Mar 21, 2024 | 322.50M | -6.17% |
Mar 20, 2024 | 343.70M | 6.57% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Novavax | 586.40M |
Nuvation Bio | 584.36M |
Stoke Therapeutics | 583.42M |
CureVac | 582.10M |
Mesoblast | 582.07M |
Prime Medicine | 575.71M |
Allogene Therapeutics | 569.84M |
Mineralys Therapeutics | 567.28M |